tirzepatide là gì is a weekly subcutaneous injection, sold under the brand names Mounjaro (mainly for type 2 diabetes) and Zepbound (mainly for obesity). It works as a dual agent, activating both glucagon-like peptide-1 ( Glucagon-Like Peptide 1 Variant:20mg Managing Stroke and Diabetes

tirzepatide là gì is a weekly subcutaneous injection, sold under the brand names Mounjaro (mainly for type 2 diabetes) and Zepbound (mainly for obesity). It works as a dual agent, activating both glucagon-like peptide-1 ( Glucagon-Like Peptide 1 Variant:20mg Managing Stroke and Diabetes

Managing Stroke and Diabetes with GLP-1 Medications | TikTok

However, early research on GLP-1 receptor agonists suggests they might have potential benefits for the brain

Glucagon-Like Peptide 1

Variant:20mg

However, the committee acknowledged that there was potential that the economic analysis underestimated health benefits as a robust assessment of long-term use of semaglutide could not be established